Nasdaq Biotechnology Ishares ETF (IBB)

$125.14 0.50 (0.40%)
9:42 EDT IBB Stock Quote Delayed 30 Minutes

3 of the Best Biotech ETFs on the Market

The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.

Why We Had to Add This Stock to Our 2020 “Screaming Buy” List

You Can’t Afford to Miss This Buying Opportunity

Use Aimmune Therapeutics to Profit off the Rush Into Biotech

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.) 167,795
Day's Range $124.71 - $125.50
52-Week Range $111.83 - $141.16
Dividend & Yield $0.61 (0.49%)